Streetbeat News

Legal

EIS

The U.S. State Department has temporarily halted additional funding for the United Nations Relief and Works Agency (UNRWA) while it investigates claims of UNRWA employee involvement in an October 7 attack on Israel. The State Department is also reviewing the actions taken by the United Nations in response to the incident.

Portfolio Pulse from Benzinga Newsdesk

January 26, 2024 | 3:03 pm

SCCO

TSLA

UBER

Tesla, Inc. (TSLA) shares fell over 12% after reporting Q4 revenue and EPS that missed consensus estimates. Southern Copper Corporation (SCCO) was downgraded by Morgan Stanley from Equal-Weight to Underweight with a reduced price target. Uber Technologies, Inc. (UBER) reached a new all-time high and is showing interest in federal marijuana lobbying, which could benefit from the SAFE Banking Act.

Portfolio Pulse from Avi Kapoor

January 26, 2024 | 1:53 pm

FRHC

Freedom Holding Corp. (FRHC) shares have risen following the completion of an external review of allegations from a short-seller report.

Portfolio Pulse from Benzinga Newsdesk

January 26, 2024 | 1:44 pm

ADTH

FOX

GOOG

NFLX

Four communication services sector stocks are showing overbought signals according to their RSI values, which may concern momentum investors. Fox Corporation (FOX) and Sinclair have renewed their affiliation agreement, boosting FOX's stock. AdTheorent Holding Company (ADTH) reported a Q3 loss but saw stock gains due to growth in key investment areas. Alphabet Inc. (GOOG) settled a major patent lawsuit, positively impacting its stock. Netflix, Inc. (NFLX) reported Q4 revenue exceeding expectations, leading to a stock increase.

Portfolio Pulse from Avi Kapoor

January 26, 2024 | 1:24 pm

LNTH

NVS

Lantheus Holdings, Inc. and its subsidiary are facing a lawsuit from Advanced Accelerator Applications, a Novartis AG unit, for patent infringement. The lawsuit concerns an Abbreviated New Drug Application (ANDA) filed for a generic version of Lutathera, known as Lutetium Lu 177 Dotatate, which is used to treat certain neuroendocrine tumors.

Portfolio Pulse from Benzinga Newsdesk

January 26, 2024 | 1:13 pm

BHP

VALE

Brazilian federal judge orders Vale SA (NYSE:VALE) and BHP Group Ltd (NYSE:BHP) to pay $9.67 billion for damages related to the 2015 dam collapse in Mariana. The collapse resulted in 19 deaths and severe pollution of the Rio Doce River. The funds are designated for repair and compensation actions. Vale has not been notified of the decision but remains committed to supporting the reparation through the Renova Foundation. Vale's and BHP's shares are down in premarket trading.

Portfolio Pulse from Lekha Gupta

January 26, 2024 | 12:55 pm

AAPL

VGK

EU Industry Chief Breton has indicated that Apple could face significant consequences if the company's App Store does not comply with the upcoming Digital Markets Act (DMA) regulations. The DMA is designed to ensure fair competition and could require changes to how Apple operates its App Store in the European market.

Portfolio Pulse from Charles Gross

January 26, 2024 | 12:46 pm

APLS

Apellis Pharmaceuticals received a negative opinion from the Committee for Medicinal Products for Human Use (CHMP) regarding its application for Pegcetacoplan for the treatment of geographic atrophy (GA) in the European Union. The company plans to request a re-examination of the application.

Portfolio Pulse from Benzinga Newsdesk

January 26, 2024 | 12:11 pm

YS

YS Biopharma's unit received a letter alleging a breach of a financial covenant related to EBITDA margin. R-Bridge has urged the unit to prepay a loan of $44.7 million by January 31, citing a material adverse effect.

Portfolio Pulse from Charles Gross

January 26, 2024 | 11:33 am

VNDA

Vanda Pharmaceuticals Inc. has received a notice of allowance from the U.S. Patent and Trademark Office for a patent application related to PONVORY® (ponesimod), which is used in the treatment of multiple sclerosis. The patent covers methods for reducing clinical management events and reinitiating treatment after missed doses, with an anticipated expiration date of October 10, 2042. Vanda plans to list the patent in the FDA's Orange Book upon issuance.

Portfolio Pulse from Benzinga Newsdesk

January 26, 2024 | 7:21 am